Duncker Streett & Co’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Buy
490
+217
+79% +$100K 0.04% 227
2026
Q1
$131K Buy
273
+3
+1% +$1.54K 0.02% 262
2025
Q4
$152K Hold
270
– – 0.03% 245
2025
Q3
$139K Sell
270
-40
-13% -$17.5K 0.02% 258
2025
Q2
$97.3K Hold
310
– – 0.02% 275
2025
Q1
$94.5K Buy
310
+30
+11% +$10.1K 0.02% 270
2024
Q4
$93K Sell
280
-259
-48% -$87.8K 0.02% 274
2024
Q3
$180K Hold
539
– – 0.03% 243
2024
Q2
$222K Buy
539
+218
+68% +$86.3K 0.04% 214
2024
Q1
$130K Buy
+321
New +$113K 0.03% 251

Other funds holding MEDP

Duncker Streett & Co's MEDP Position: Q2 2026 in Review

Duncker Streett & Co increased its Medpace (MEDP) stake by 79% in Q2 2026, buying an estimated $100K and bringing the position to 490 shares worth $259K. The position accounts for 0.04% of the portfolio, ranked #227.

Duncker Streett & Co first reported a position in MEDP in Q1 2024 and has held it in 10 quarters since. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Duncker Streett & Co held 490 shares of Medpace worth $259K as of Q2 2026.
  • Duncker Streett & Co bought 217 Medpace shares in Q2 2026, an estimated $100K.
  • Medpace made up 0.04% of Duncker Streett & Co's portfolio in Q2 2026, its #227 holding.
  • Duncker Streett & Co first reported a position in Medpace in Q1 2024 and has held it in 10 quarters since.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Duncker Streett & Co's 13F filing for Q2 2026, filed 28 Jul 2026.